What's Going On With Molecular Templates Stock?

on MSN ago, source:

Molecular Templates, Inc (NASDAQ:MTEM) shares are volatile Tuesday after the company presented interim data from MT-6402 ...

Molecular Templates gets grant for pd-L1 binding molecule for treating cancer

14h ago, source: Pharmaceutical Technology

Discover how Molecular Templates Inc's patent for PD-L1 binding molecules conjugated to a toxin offers a groundbreaking method for treating cancer in humans with PD-L1 expressing tumors. Targeting ...

MTEM Molecular Templates, Inc.

1mon ago, source: Seeking Alpha

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in ...

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

20d ago, source: Nasdaq

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...

Molecular Templates (NASDAQ: MTEM)

3d ago, source: The Motley Fool

Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary ...

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

20d ago, source: Yahoo Finance

Molecular Templates, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) (unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 ...

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

21d ago, source: Stockhouse

Durable single agent activity observed with MT-6402, a PD-L1 targeting direct-cell kill agent, in heavily pre-treated patients with low PD-L1+ head and neck cancer who had progressed on multiple prior ...

Molecular Templates Inc MTEM

28d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...